The U.S. cannabis market continues to face dramatic policy changes at both the federal and state level, and Benesch’s Cannabis insights help businesses understand what’s coming next. A U.S. House subcommittee has advanced a bill barring the Department of Justice from rescheduling cannabis, directly opposing the Biden administration’s push to reclassify marijuana under the Controlled Substances Act. For companies following Benesch’s Cannabis guidance, this is a critical development that could reshape compliance strategies nationwide.
Read More: Benesch’s Cannabis Q3 2025 Insights
Comments are closed, but trackbacks and pingbacks are open.